These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE. Surányi P; Mátyus L; Sonkoly I; Szegedi G Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918 [TBL] [Abstract][Full Text] [Related]
25. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637 [TBL] [Abstract][Full Text] [Related]
26. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE. Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522 [TBL] [Abstract][Full Text] [Related]
27. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets. Auer IO; Röder A; Fröhlich J Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166 [TBL] [Abstract][Full Text] [Related]
28. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. Moutsopoulos HM; Fauci AS J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308 [TBL] [Abstract][Full Text] [Related]
29. Studies of immune abnormalities in systemic lupus erythematosus. Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146 [TBL] [Abstract][Full Text] [Related]
30. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187 [TBL] [Abstract][Full Text] [Related]
31. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. Gottlieb AB; Lahita RG; Chiorazzi N; Kunkel HG J Clin Invest; 1979 May; 63(5):885-92. PubMed ID: 312809 [TBL] [Abstract][Full Text] [Related]
32. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens. Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744 [TBL] [Abstract][Full Text] [Related]
33. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus. Smolen JS; Siminovitch K; Luger TA; Steinberg AD Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332 [TBL] [Abstract][Full Text] [Related]
34. Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus. Hari Kumar MK; Knight RA; Snaith ML Clin Exp Immunol; 1984 Oct; 58(1):21-8. PubMed ID: 6236917 [TBL] [Abstract][Full Text] [Related]
35. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925 [TBL] [Abstract][Full Text] [Related]
36. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [TBL] [Abstract][Full Text] [Related]
37. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]
39. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus. Sierakowski S; Kucharz EJ Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032 [TBL] [Abstract][Full Text] [Related]
40. Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus. Gómez J; Prado C; López P; Suárez A; Gutiérrez C Clin Immunol; 2009 Sep; 132(3):385-92. PubMed ID: 19540813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]